NCT02711202 2026-04-13Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney TransplantationInstitute for Clinical and Experimental MedicinePhase NA Completed20 enrolled 11 charts